NSCLC drug development

Oncology

Targeted therapies have transformed the treatment landscape for non-small cell lung cancer (NSCLC) over the past decade.

Events

Partner Content

Transforming NSCLC standards of care

News

Cell therapy developer Legend Biotech has named Ingrid Zhang as its new chief executive, ending its search for new leadership.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.